The Nitrofurantoin 25 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or tablets, such as children and the elderly. Nitrofurantoin is an antibiotic that is commonly prescribed to treat urinary tract infections (UTIs).

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Nitrofurantoin 25 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, providing a precise 25 mg dose of nitrofurantoin in every 5 mL of liquid. This formulation is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly, or for those who prefer a liquid medication. Nitrofurantoin is an antibiotic that is commonly used to treat and prevent urinary tract infections (UTIs) caused by certain bacteria. It works by inhibiting the synthesis of bacterial cell walls, thereby leading to the elimination of the infection-causing bacteria.
The liquid form of nitrofurantoin ensures that patients receive an accurate dose, which is essential for the effectiveness of the treatment and the prevention of resistance. It is important for patients to take this medication exactly as prescribed by their healthcare provider and to complete the full course of therapy, even if symptoms improve before the medication is finished. This helps to ensure that the infection is fully treated and reduces the risk of the bacteria developing resistance to the antibiotic.
Patients should be advised that nitrofurantoin may cause side effects such as nausea, vomiting, loss of appetite, and diarrhea. If these or other side effects persist or worsen, they should contact their healthcare provider. Additionally, patients should be informed that nitrofurantoin should not be used for treating infections outside of the urinary tract, as its efficacy is limited to this specific area.
Prescribers should consider the patient's renal function when prescribing nitrofurantoin, as its clearance is significantly reduced in patients with renal impairment, which may necessitate dosage adjustments or alternative treatments. Furthermore, nitrofurantoin is contraindicated in patients with a history of hypersensitivity to the drug, significant renal impairment, or in those at the end of term pregnancy, during labor and delivery, or in neonates under one month of age.
For any questions or additional information regarding the use of Nitrofurantoin 25 mg/5 mL Oral Liquid, or to discuss specific patient needs, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing the highest quality of care and is available to support both patients and healthcare providers with their medication needs.
Nitrofurantoin is an antibiotic commonly used to treat and prevent urinary tract infections (UTIs). When considering the use of nitrofurantoin 25 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects. Patients should inform their healthcare provider of all medications they are currently taking, including prescription drugs, over-the-counter medications, herbal supplements, and vitamins.
One significant interaction is with antacids containing magnesium trisilicate, which can decrease the absorption of nitrofurantoin, leading to reduced effectiveness. Patients should avoid taking antacids within a couple of hours of their nitrofurantoin dose. Similarly, drugs that acidify the urine, such as ammonium chloride and ascorbic acid, can decrease the drug's efficacy by reducing its renal concentration and should be used with caution.
Conversely, drugs that alkalinize the urine, such as sodium bicarbonate, may increase the therapeutic effect of nitrofurantoin by promoting higher renal drug concentrations. However, this could also increase the risk of toxicity, and careful monitoring is advised. Probenecid and sulfinpyrazone, medications used to treat gout, can inhibit the renal excretion of nitrofurantoin, leading to increased blood levels and potential toxicity. These drugs should be avoided or used with caution in patients receiving nitrofurantoin.
Patients on quinolone antibiotics should also be cautious, as there may be a reduced antibacterial effect when used concurrently with nitrofurantoin. Additionally, nitrofurantoin may interfere with the results of certain lab tests, such as urinary glucose tests or urinary catecholamine tests, leading to false results. Healthcare providers should be made aware of nitrofurantoin use prior to testing.
It is also important to note that nitrofurantoin should not be used in patients with significant renal impairment, as decreased renal function can lead to drug accumulation and increased risk of toxicity. The effectiveness of nitrofurantoin is also reduced in these patients due to lower urinary concentrations of the drug.
Lastly, nitrofurantoin may cause pulmonary reactions, and the risk may be increased when combined with other medications known to cause pulmonary toxicity, such as certain chemotherapy agents. Patients should be monitored for signs of pulmonary distress, and healthcare providers should be informed of any existing lung conditions before starting treatment with nitrofurantoin.
This is not an exhaustive list of all potential interactions with nitrofurantoin. It is essential to consult with a healthcare provider for a complete assessment of possible drug interactions based on individual health conditions and medication profiles. If you have any questions or concerns regarding the use of nitrofurantoin 25 mg/5 mL oral liquid or its interactions with other medications, please reach out to us at Bayview Pharmacy for further assistance.
The Nitrofurantoin 25 mg/5 mL Oral Liquid is a specially compounded medication designed for ease of administration and accurate dosing. Nitrofurantoin is an antibiotic agent that works by inhibiting the synthesis of bacterial DNA, RNA, and cell wall proteins, leading to the disruption of vital cellular processes in the bacteria.
Upon oral administration, the liquid formulation of Nitrofurantoin is absorbed from the gastrointestinal tract and quickly begins its action within the urinary tract. The drug is specifically concentrated in the urine, which allows it to directly target the site of infection.
This liquid formulation is ideal for patients who have difficulty swallowing pills, such as children and the elderly, or for those who may have certain gastrointestinal conditions that impede the absorption of solid dosage forms. The 25 mg/5 mL concentration allows for flexible dosing, which can be adjusted according to the specific needs of the patient, their kidney function, and the severity of the infection. The liquid form also allows for a more pleasant administration experience, as it can be flavored to mask the bitter taste of the medication.
Nitrofurantoin is primarily used to treat and prevent uncomplicated UTIs caused by susceptible strains of bacteria. It is important to note that Nitrofurantoin should only be used under the guidance of a healthcare provider, as inappropriate use can lead to resistance and decreased effectiveness of the medication.
For optimal results, patients are advised to take the medication exactly as prescribed, at evenly spaced intervals, to maintain a consistent level of drug in the body. Completing the full course of therapy is crucial, even if symptoms improve before the medication is finished, to ensure the complete eradication of the infection and to prevent the development of resistant bacteria.
If you have any questions about the Nitrofurantoin 25 mg/5 mL Oral Liquid or its use in treating urinary tract infections, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to effectively manage your health or the health of your patients.
Nitrofurantoin 25 mg/5 mL Oral Liquid is commonly prescribed to treat and prevent urinary tract infections (UTIs), particularly when caused by bacteria that are susceptible to nitrofurantoin. Its liquid form makes it especially suitable for patients who have difficulty swallowing pills, such as children and elderly individuals.
This medication should be stored at room temperature, away from light and moisture. Do not store it in the bathroom, and keep it out of reach of children and pets to prevent accidental ingestion.
Nitrofurantoin Oral Liquid should be taken exactly as prescribed by your healthcare provider. The medication is usually taken with food to enhance absorption and to reduce the risk of stomach upset. Shake the bottle well before each use, and use the accompanying measuring device to ensure an accurate dose.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses to make up for a missed one.
As with any medication, Nitrofurantoin Oral Liquid may cause side effects. Common side effects include nausea, vomiting, loss of appetite, and diarrhea. If you experience any severe side effects such as persistent headache, vision changes, or symptoms of a new infection, contact your healthcare provider immediately.
Before starting Nitrofurantoin Oral Liquid, it is important to discuss your current medications with your healthcare provider, as it may interact with other drugs. Some interactions can affect the effectiveness of the medication or increase the risk of side effects.
Nitrofurantoin is typically not recommended for use at the very end of pregnancy or during labor and delivery. It should only be used when clearly needed during pregnancy and breastfeeding. Discuss the risks and benefits with your healthcare provider if you are pregnant or planning to become pregnant or are breastfeeding.
The duration of treatment with Nitrofurantoin Oral Liquid varies based on the nature and severity of the infection, as well as patient-specific factors. It is important to complete the full course of treatment as prescribed, even if symptoms improve before the medication is finished.
Consuming alcohol during treatment with Nitrofurantoin Oral Liquid may increase the risk of certain side effects, such as upset stomach or dizziness. It is generally advisable to avoid alcohol until you have finished your course of medication and are symptom-free.
If you experience symptoms of an allergic reaction, such as rash, itching, swelling, severe dizziness, or trouble breathing, seek immediate medical attention. Allergic reactions to this medication are serious and require prompt treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally